HDAC6 and cancer: In addition to the above suggested common targets, Kmp docked the active sites of the AKT1 Kinase, PI3Kβ phosphatidylinositol-3-kinase, and Histone deacetylase 6 catalytic domain 1 HDAC6 CD1 with high binding energies, all of which have been identified as prospective cancer-targeting options [43–45].